Table 2 The univariate analysis analysis for related factors of MRI remission
Non-remission (N = 35) | Remission (N = 27) | P value | |
|---|---|---|---|
Male sex, n (%) | 19 (54.3) | 16 (59.3) | 0.304 |
Age at onset, y | 9.3 ± 2.7 | 9.4 ± 3.6 | 0.936 |
Duration from onset to diagnosis ≤ 3 m, n (%) | 13 (37.1) | 19 (70.4) | 0.009 |
Family history, n (%) | 1 (2.9) | 3 (11.1) | 0.215 |
AJC > 4, n (%) | 4 (11.4) | 9 (33.3) | 0.037 |
Back pain, n (%) | 7 (20) | 6 (22.2) | 0.537 |
Hip arthritis, n (%) | 19 (54.3) | 13 (48) | 0.412 |
Knee arthritis, n (%) | 15 (42.9) | 16 (59.3) | 0.153 |
Enthesitis, n (%) | 13 (37.1) | 4 (14.8) | 0.046 |
ESR at diagnosis, mm/h | 20.5 ± 26.9 | 23.8 ± 29.6 | 0.645 |
CRP at diagnosis, mg/L | 15.6 ± 42.0 | 11.7 ± 26.1 | 0.673 |
TNF-a, pg/ml | 30.9 ± 41.0 | 17.2 ± 21.6 | 0.095 |
FER, ug/L | 89.6 ± 105.9 | 100.1 ± 122.4 | 0.772 |
IgG, g/L | 11.5 ± 3.1 | 12.8 ± 4.1 | 0.201 |
IgA, g/L | 1.6 ± 0.7 | 1.8 ± 1.0 | 0.394 |
IgM, g/L | 1.3 ± 0.9 | 1.3 ± 0.5 | 0.960 |
IgE, g/L | 208.9 ± 295.6 | 224.5 ± 526.0 | 0.922 |
B27 (+), n (%) | 8 (22.9) | 6 (22.2) | 0.600 |
ANA (+), n (%) | 2 (5.7) | 5 (18.5) | 0.121 |
JSpADA | 2.2 ± 0.6 | 2.5 ± 0.8 | 0.058 |
Biogics, n (%) | 27 (77.1) | 22 (81.5) | 0.463 |